相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Conditioning of amitriptyline-induced REM sleep suppression in healthy participants: A randomized controlled trial
Alexander Winkler et al.
PSYCHOPHYSIOLOGY (2016)
Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines
Anthony Cleare et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Nocebo effects and psychotropic drug action
Martina Amanzio
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2015)
Neuro-Bio-Behavioral Mechanisms of Placebo and Nocebo Responses: Implications for Clinical Trials and Clinical Practice
Manfred Schedlowski et al.
PHARMACOLOGICAL REVIEWS (2015)
Risk factors for non-adherence to antidepressant treatment in patients with mood disorders
Carlos De las Cuevas et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications
V. Abbing-Karahagopian et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2014)
National Trends in Long-Term Use of Antidepressant Medications: Results From the US National Health and Nutrition Examination Survey
Ramin Mojtabai et al.
JOURNAL OF CLINICAL PSYCHIATRY (2014)
Social Inequalities in Early Antidepressant Discontinuation
Aurelie Bocquier et al.
PSYCHIATRIC SERVICES (2014)
Optimizing expectations to prevent side effects and enhance quality of life in breast cancer patients undergoing endocrine therapy: study protocol of a randomized controlled trial
Pia von Blanckenburg et al.
BMC CANCER (2013)
OPINION The placebo response in medicine: minimize, maximize or personalize?
Paul Enck et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Nocebo in Headaches: Implications for Clinical Practice and Trial Design
Dimos D. Mitsikostas
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2012)
Placebo Effects on the Immune Response in Humans: The Role of Learning and Expectation
Antje Albring et al.
PLOS ONE (2012)
Nonconscious activation of placebo and nocebo pain responses
Karin B. Jensen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Utilizing placebo mechanisms for dose reduction in pharmacotherapy
Bettina K. Doering et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
Risk factors for drug nonadherence in antidepressant-treated patients and implications of pharmacist adherence instructions for adherence improvement
Atsunobu Murata et al.
PATIENT PREFERENCE AND ADHERENCE (2012)
Comorbidities and factors related to discontinuation of pharmacotherapy among outpatients with major depressive disorder
Ching-I Hung et al.
COMPREHENSIVE PSYCHIATRY (2011)
Lessons learned from placebo groups in antidepressant trials
Meike Shedden Mora et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2011)
The Nocebo Effect and Its Relevance for Clinical Practice
Luana Colloca et al.
PSYCHOSOMATIC MEDICINE (2011)
Duration and adherence of antidepressant treatment (2003 to 2007) based on prescription database
M. C. Serna et al.
EUROPEAN PSYCHIATRY (2010)
Conditioned effects of caffeine on performance in humans
Angela Attwood et al.
PHYSIOLOGY & BEHAVIOR (2010)
How the number of learning trials affects placebo and nocebo responses
Luana Colloca et al.
PAIN (2010)
Conditioned Pharmacotherapeutic Effects: A Preliminary Study
Robert Ader et al.
PSYCHOSOMATIC MEDICINE (2010)
Prediction of Nonspecific Side Effects in Rheumatoid Arthritis Patients by Beliefs About Medicines
Yvonne Nestoriuc et al.
ARTHRITIS CARE & RESEARCH (2010)
Persistence and compliance to antidepressant treatment in patients with depression: A chart review
Norifusa Sawada et al.
BMC PSYCHIATRY (2009)
Differences in Adverse Effect Reporting in Placebo Groups in SSRI and Tricyclic Antidepressant Trials A Systematic Review and Meta-Analysis
Winfried Rief et al.
DRUG SAFETY (2009)
Gender and the nocebo response following conditioning and expectancy
Sibylle Klosterhalfen et al.
JOURNAL OF PSYCHOSOMATIC RESEARCH (2009)
A systematic review of adverse events in placebo groups of anti-migraine clinical trials
Martina Amanzio et al.
PAIN (2009)
The role of learning in nocebo and placebo effects
L. Colloca et al.
PAIN (2008)
Behavioral conditioning of antihistamine effects in patients with allergic rhinitis
Marion U. Goebel et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2008)
Finasteride 5 mg and sexual side effects: How many of these are related to a nocebo phenomenon?
Nicola Mondaini et al.
JOURNAL OF SEXUAL MEDICINE (2007)
Sensitivity of an instrumental variable analysis to treatment effect heterogeneity and violations of structural assumptions
M. Alan Brookhart et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Using structured audits to increase the percentage of patients achieving an agreed lipid lowering target
Philip S. Woodvine et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Fibrosis progression among patients transplanted for HCV-related liver disease: A systematic literature review
Nataliya Volkova et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Initial treatment effectiveness of acute sinusitis in a representative national cohort
Patrick Blin et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Use of a fully sequential design to assess post-licensure vaccine effectiveness of a hepatitis B vaccine regimen
Walter Straus et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Evaluation of stress urinary incontinence and suicidality among females in the general practice research database
Indiana M. Strombom et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Cholesterol level and subsequent use of statins: A prospective study of 6700 men and women aged 59-61 years
Randi Selmer et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Characteristics and pattern of treatment in newly diagnosed patients with anxiety and depression in primary care
Ana Ruigomez et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Risk of impaired renal function after colonoscopy: A cohort study in patients receiving either oral sodium phosphate or polyethylenglycol
Stefan Russmann et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Descriptive epidemiology, patterns of anticoagulant use, and outcomes among patients with atrial fibrillation
Dimitri Bennett
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Patterns and predictors of anticoagulant use among patients with atrial fibrillation
Dimtitri Bennett
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
An epidemiologic study of health outcomes among patients with psoriasis
Susan A. Oliveria et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Validity of benzodiazepine exposure measured from patient interview: Data from the 3C cohort
Pernelle Noize et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Strengths and limitations of drug abuse warning network data used in a surveillance study
Kirk Midkiff et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Prescribing in dyspepsia before and after the introduction of NICE guidelines
Anita McGrogan et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Measuring quality of care - Laboratory monitoring for rheumatoid arthritis
Jyotsna Mehta et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
A comparison of prescription refill adherence and patients' report to identify non-adherence with inhaled corticosteroids
T. T. Menckeberg et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Cardiovascular diseases' risk in Portugal
Ana Macedo et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Determinants of cholesterol and triglycerides recording in patients treated with lipid lowering therapy in UK primary care
Andrew Maguire et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Potential for detection bias: Diabetes therapies and colorectal neoplasia
James D. Lewis et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Feasibility of conducting a pragmatic cluster cohort study using administrative databases to evaluate the effectiveness of an osteoporosis workshop to family physicians
Marie-Claude Laliberte et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Corons study: Preliminary analysis on the effect of statins in a large population-based cohort in elderly
Alexia Kieffer et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Sample size calculation for an epidemiologic study with an unknown background/expected rate or proportion
Kui Huang et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Researchers were able to obtain 78% of requested hospital records to validate medicaid and medicare claims while complying with HIPAA
Sean Hennessy et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Proton pump inhibitor (PPI) use and pneumonia risk in veteran patients with and without co-morbidities
John Hermos et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Prevalence of overactive bladder: Canadian results from the epic study
S. Herschorn et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Prevalence of lower urinary tract symptoms (LUTS) in men: Canadian results from the epic study
S. Herschorn et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
A quantitative analysis of spontaneous reports of muscle injury with proton pump inhibitors
M. Hauben et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Patient specific provider feedback effective in a range of target conditions
Andrew Gilbert et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Factors associated with interview completion rates in a surveillance study of osteosarcoma and antecedent exposures
Alicia W. Gilsenan et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Understanding and assessing registries for evaluating patient outcomes
Nancy A. Dreyer et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Validation of diagnoses of hospitalizations due to peptic ulcer complications: Results using the TennCare database
Cecilia P. Clump et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Underutilization of current guidelines for testing and treatment of H. pylori infection in patients with peptic ulcer disease: Results from a pilot study
Cecilia P. Chung et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Projecting diabetes prevalence and treatment rates to the US employer-insured population
Stella Chang et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Age and gender specific incidence of hospitalization for digoxin intoxication
Albert-Jan L. H. J. Aarnoudse et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences
Franz Faul et al.
BEHAVIOR RESEARCH METHODS (2007)
Medication-attributed adverse effects in placebo groups - Implications for assessment of adverse effects
W Rief et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Symptoms following abrupt discontinuation of duloxetine treatment in patients with major depressive disorder
DG Perahia et al.
JOURNAL OF AFFECTIVE DISORDERS (2005)
Antidepressant-related adverse effects impacting treatment compliance: Results of a patient survey
AK Ashton et al.
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL (2005)
The placebo effect: Dissolving the expectancy versus conditioning debate
S Stewart-Williams et al.
PSYCHOLOGICAL BULLETIN (2004)
The role of behavioral conditioning in the development of nausea
S Matteson et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2002)
Nonspecific medication side effects and the nocebo phenomenon
AJ Barsky et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Multiple recurrences of major depressive disorder
DA Solomon et al.
AMERICAN JOURNAL OF PSYCHIATRY (2000)
分享论文
